RVMD: revmed.com Cash per Share

Revolution Medicines - graphic logo of issuer RVMD

Revolution Medicines is developing cutting-edge oncology treatments, anticipating monopoly pricing following successful trials. This cash per share chart illustrates liquidity dynamics, with the value stabilizing at 16.87. Revolution Medicines is building a closed intellectual property system in therapy and implementing automated laboratories to accelerate the selection of drug formulas.

RVMD: RevMed Cash per Share 07/04/2022 - 11/20/2026

Analytical breakdowns for Revolution Medicines

- stock quotes and analyst forecast:
- cash availability and cash flow indicators:
General company analysis:Revolution Medicines Corp - RVMD
Original product of Revolution Medicines Inc

For Revolution Medicines (RVMD), whose model depends on costly oncology research in the absence of regular revenue, maintaining a high level of liquidity is critical. An analysis of cash per share allows for an assessment of the net cash component in the value of each security, determining the company's financial cushion against potential clinical trial failures and its overall capital stability.

Analysis of competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash Calculated per Single Share AAPG|Cash Funds per Share CG Oncology Therapeutics CGON|Amount of Cash per Share URGN|BCAX: Cash per Single Share|PSNL: Cash Funds per Share|Erasca (ERAS) - Cash Funds per Share|DCTH - Cash Funds Calculated per Share|YMAB (Y-mAbs Corp) - Cash per Share|Cash per Single Share Aura Biosciences (AURA)|Cash Funds per Share Candel Therapeutics Inc. (CADL)|Cash per Single Share Accuray, Inc. ARAY|Cash Funds per Share sellaslifesciences.com SLS|Amount of Cash per Share ACTU|CTOR - Cash Funds per Share|Cash Funds Calculated per Share tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Cash Funds per Share|FATE: Cash Calculated per Single Share|WHWK (Aadi Bioscience, Inc.) - Cash per Share|TCRX (TScan Therapeutics) - Cash Calculated per Single Share|Cash Funds per Share Champions Oncology (CSBR)|Cash Funds Calculated per Share XBiotech USA|Cash Funds per Share CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Cash on Hand per Share|RADX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com